These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24108210)

  • 21. Determination of faecal inflammatory marker concentration as a noninvasive method of evaluation of pathological activity in children with inflammatory bowel diseases.
    Roszak D; Gałęcka M; Cichy W; Szachta P
    Adv Med Sci; 2015 Sep; 60(2):246-52. PubMed ID: 25989184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutations in pattern recognition receptor genes modulate seroreactivity to microbial antigens in patients with inflammatory bowel disease.
    Henckaerts L; Pierik M; Joossens M; Ferrante M; Rutgeerts P; Vermeire S
    Gut; 2007 Nov; 56(11):1536-42. PubMed ID: 17595233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fecal markers: calprotectin and lactoferrin.
    Abraham BP; Kane S
    Gastroenterol Clin North Am; 2012 Jun; 41(2):483-95. PubMed ID: 22500530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Indicators of inflammatory process in stool in diagnostics and monitoring of inflammatory bowel diseases].
    Iwańczak B; Iwańczak F
    Pol Merkur Lekarski; 2015 Dec; 39(234):389-92. PubMed ID: 26802694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical utility of calprotectin and lactoferrin in patients with inflammatory bowel disease: is there something new from the literature?
    Caccaro R; D'Incà R; Pathak S; Sturniolo GC
    Expert Rev Clin Immunol; 2012 Aug; 8(6):579-85. PubMed ID: 22992152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease.
    Gisbert JP; McNicholl AG
    Dig Liver Dis; 2009 Jan; 41(1):56-66. PubMed ID: 18602356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evolving concepts on inflammatory bowel disease. Are we happy with the present nosology?
    Caprilli R; Viscido A
    Ital J Gastroenterol Hepatol; 1999 Dec; 31(9):893-7. PubMed ID: 10670000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease.
    Canani RB; Terrin G; Rapacciuolo L; Miele E; Siani MC; Puzone C; Cosenza L; Staiano A; Troncone R
    Dig Liver Dis; 2008 Jul; 40(7):547-53. PubMed ID: 18358796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New serologic markers for inflammatory bowel disease diagnosis.
    Dotan I
    Dig Dis; 2010; 28(3):418-23. PubMed ID: 20926866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic performance of rapid tests for detection of fecal calprotectin and lactoferrin and their ability to discriminate inflammatory from irritable bowel syndrome.
    Otten CM; Kok L; Witteman BJ; Baumgarten R; Kampman E; Moons KG; de Wit NJ
    Clin Chem Lab Med; 2008; 46(9):1275-80. PubMed ID: 18597588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What is the faecal calprotectin test?
    Drug Ther Bull; 2014 Sep; 52(9):102-4. PubMed ID: 25213590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serologic markers in inflammatory bowel disease (IBD).
    Nakamura RM; Barry M
    MLO Med Lab Obs; 2001 Nov; 33(11):8-15; quiz 16-9. PubMed ID: 11721286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular diagnosis and classification of inflammatory bowel disease.
    Zhang H; Zeng Z; Mukherjee A; Shen B
    Expert Rev Mol Diagn; 2018 Oct; 18(10):867-886. PubMed ID: 30152711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fecal lactoferrin is a sensitive and specific marker of disease activity in children and young adults with inflammatory bowel disease.
    Walker TR; Land ML; Kartashov A; Saslowsky TM; Lyerly DM; Boone JH; Rufo PA
    J Pediatr Gastroenterol Nutr; 2007 Apr; 44(4):414-22. PubMed ID: 17414136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year.
    Guidi L; Marzo M; Andrisani G; Felice C; Pugliese D; Mocci G; Nardone O; De Vitis I; Papa A; Rapaccini G; Forni F; Armuzzi A
    Dig Liver Dis; 2014 Nov; 46(11):974-9. PubMed ID: 25096964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serological markers in inflammatory bowel disease: a review of their clinical utility.
    Barahona-Garrido J; Sarti HM; Barahona-Garrido MK; Hernández-Calleros J; Coss-Adame E; Garcia-Saenz SM; Yamamoto-Furusho JK
    Rev Gastroenterol Mex; 2009; 74(3):230-7. PubMed ID: 19858012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Fecal calprotectin: a diagnostic tool for inflammatory bowel disease].
    Fraga M; Godat S; Nydegger A; Moradpour D; Schoepfer AM
    Rev Med Suisse; 2012 Sep; 8(352):1669-70, 1672-3. PubMed ID: 22988727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular Analysis of Inflammatory Bowel Disease: Clinically Useful Tools for Diagnosis, Response Prediction, and Monitoring of Targeted Therapy.
    Jiang W; Li X
    Mol Diagn Ther; 2015 Jun; 19(3):141-58. PubMed ID: 25990388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Laboratory diagnosis in inflammatory bowel disease].
    Seibold F
    Ther Umsch; 2003 Mar; 60(3):133-6. PubMed ID: 12693315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diagnostic tools in inflammatory bowel diseases].
    Bouhnik Y
    Rev Prat; 2005 May; 55(9):977-83. PubMed ID: 16052968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.